Understanding substance misuse among young adults injured in assaults
Alcohol and Cannabis Misuse Among Assault-Injured Emerging Adults
This study is looking at how drinking alcohol and using cannabis can lead to injuries from fights in young adults aged 18-25, and it aims to find ways to help them cut back on these substances while they’re getting treated in emergency rooms.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-11137418 on NIH RePORTER |
What this research studies
This research investigates the relationship between alcohol and cannabis misuse and assault injuries in emerging adults aged 18-25. It aims to identify the psychosocial factors that contribute to substance misuse in this population, particularly in the context of injuries sustained from assaults. The study will utilize brief motivational interventions, such as the Brief Negotiation Interview, to encourage participants to reduce their substance use during their treatment in emergency departments. By focusing on this high-risk group, the research seeks to develop effective interventions that can be implemented in acute medical care settings.
Who could benefit from this research
Good fit: Ideal candidates for this research are emerging adults aged 18-25 who have experienced assault injuries and may also struggle with alcohol or cannabis misuse.
Not a fit: Patients who are not within the 18-25 age range or who have not experienced assault injuries may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved interventions that reduce substance misuse and subsequent assault injuries among young adults.
How similar studies have performed: Previous research has shown that brief motivational interventions can effectively reduce substance use in emergency department settings, indicating a promising approach for this study.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: Coupet, Edouard — Yale University
- Study coordinator: Coupet, Edouard
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.